Sanara Medtech Inc Asset Resilience Ratio
Sanara Medtech Inc asset resilience ratio. Sanara Medtech Inc (SMTI) has an Asset Resilience Ratio of 10.33% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SMTI days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sanara Medtech Inc (2020–2020)
Asset resilience ratio of Sanara Medtech Inc from 2020 to 2020. This chart shows how Sanara Medtech Inc's Asset Resilience Ratio has changed over time. Read SMTI total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sanara Medtech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sanara Medtech Inc assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $4.01 Million | 10.33% |
| Total Liquid Assets | $4.01 Million | 10.33% |
Asset Resilience Insights
- Moderate Liquidity: Sanara Medtech Inc has 10.33% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Sanara Medtech Inc Industry Peers by Asset Resilience Ratio
Compare Sanara Medtech Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.55% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Sanara Medtech Inc Asset Resilience Ratio by Year (2020–2020)
Sanara Medtech Inc asset resilience ratio by year from 2020 to 2020. The table below shows the annual Asset Resilience Ratio data for Sanara Medtech Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 11.19% | $1.10 Million | $9.83 Million | -- |
About Sanara Medtech Inc
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and seco… Read more